CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Mar. 29, 2025	Mar. 30, 2024
Operating activities:
Net loss	$ (4,394)	$ (802)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization	7,945	8,247
Amortization of interest rate swap	0	97
Amortization of deferred loan costs	1,413	221
Noncash lease expense	3,607	4,289
Provision for warranty	17	129
Provision for credit losses	740	49
Loss (gain) on disposal of assets	2	(32)
Gain on insurance proceeds, net of losses	0	(431)
Share-based compensation expense	109	163
Deferred income taxes	(4,445)	(2,578)
Noncash accrued compensation benefit	0	(3,907)
Changes in operating assets and liabilities:
Trade receivables	19,574	14,909
Contract assets	2,221	1,306
Inventories	5,769	22,796
Other assets	(7,284)	(1,500)
Accounts payable	(14,127)	(33,701)
Accrued compensation and vacation	(653)	(2,374)
Other liabilities	(376)	(800)
Cash provided by operating activities	10,118	6,081
Investing activities:
Purchase of property and equipment	(3,020)	(3,398)
Proceeds from insurance	0	2,365
Cash used in investing activities	(3,020)	(1,033)
Financing activities:
Payment of financing costs	(2,681)	(706)
Repayments of long term debt	(3,533)	(2,214)
Borrowings under revolving credit agreement	347,835	403,034
Repayments of revolving credit agreement	(376,932)	(400,840)
Principal payments on finance leases	(2,071)	(3,831)
Proceeds from issuance of long-term debt	28,000	1,161
Cash used in financing activities	(9,382)	(3,396)
Net (decrease) increase in cash and cash equivalents	(2,284)	1,652
Cash and cash equivalents, beginning of period	4,752	3,603
Cash and cash equivalents, end of period	2,468	5,255
Supplemental cash flow information:
Interest payments	8,405	8,841
Income tax payments, net of refunds	902	1,899
Recognition of operating lease liabilities and right-of-use assets	$ 784	$ 3,621